Clinical Trials Browser

Recruiting × Interventional × Endometriosis × Clear all

Uterine Cervical Neoplasms, Endometriosis, Leiomyoma, Menstruation Disturbances, Ovarian Neoplasms, Precancerous Conditions, Uterine Prolapse, Endometrial Neoplasms, Adenomyosis

NCT04154683 2026-01-15

GYNECOPTIC

Phase NA Recruiting

80 enrolled

Gynecologic

Endometriosis, Ovarian Neoplasms

NCT05726786 2025-12-09

INCyst

Phase 3 Recruiting

232 enrolled

Genitourinary

Cystitis, Hemorrhagic, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic, Endometriosis, Cystitis, Interstitial, Malnutrition

NCT04567771 2025-11-14

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

Phase NA Recruiting

120 enrolled

Gynecologic

Pelvic Inflammatory Disease, Uterine Cervical Neoplasms, Endometriosis, Endometrial Neoplasms

NCT07173127 2025-09-15

The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters

Phase NA Recruiting

30 enrolled

Endometriosis, Leiomyoma

NCT05862272 2025-08-06

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

Phase 3 Recruiting

1,000 enrolled

Endometriosis, Leiomyoma, Myofibroma

NCT06891690 2025-03-24

tDCS

Phase NA Recruiting

300 enrolled

Dysmenorrhea, Dyspareunia, Endometriosis, Pain, Polycystic Ovary Syndrome, Radiculopathy, Spinal Cord Diseases, Stroke

Clinical Trials

Embrace Gyn

GYNECOPTIC

INCyst

Comparison of Proton or Intensity Modulated Radiation Therapy After Surgery for Endometrial or Cervical Cancer

The Impact of a Novel GnRH Antagonist With Add-back Therapy for Treatment of Uterine Fibroids and Endometriosis on Hemostasis Parameters

A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis

tDCS